We are live on ! Find out more
ETC

Exchange Traded Concepts Portfolio holdings

AUM $21.9B
1-Year Est. Return 68.6%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+68.6%
3 Year Est. Return
+158.93%
5 Year Est. Return
+186.62%
10 Year Est. Return
AUM
$4.06B
AUM Growth
+$411M
Cap. Flow
+$205M
Cap. Flow %
5.05%
Top 10 Hldgs %
21.64%
Holding
1,420
New
288
Increased
397
Reduced
560
Closed
115

Sector Composition

Rank Sector Weight
1 Technology 20.96%
2 Energy 10.24%
3 Healthcare 10.11%
4 Industrials 5.84%
5 Consumer Discretionary 5.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWAV
901
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$124K ﹤0.01%
433
-8
-2% -$2.22K
CRBU icon
902
Caribou Biosciences
CRBU
$149M
$124K ﹤0.01%
+29,068
New +$131K
RAPT
903
DELISTED
RAPT Therapeutics
RAPT
$123K ﹤0.01%
+825
New +$129K
NRIX icon
904
Nurix Therapeutics
NRIX
$2.38B
$123K ﹤0.01%
+12,339
New +$126K
FATE icon
905
Fate Therapeutics
FATE
$266M
$122K ﹤0.01%
25,611
-196,990
-88% -$1.09M
TSVT
906
DELISTED
2seventy bio
TSVT
$122K ﹤0.01%
+12,036
New +$127K
RPTX
907
DELISTED
Repare Therapeutics
RPTX
$121K ﹤0.01%
+11,445
New +$118K
EVRI
908
DELISTED
Everi Holdings
EVRI
$120K ﹤0.01%
+8,292
New +$126K
DKS icon
909
Dick's Sporting Goods
DKS
$18.7B
$120K ﹤0.01%
907
-288
-24% -$39.4K
PINS icon
910
Pinterest
PINS
$13.4B
$119K ﹤0.01%
4,367
-792
-15% -$19.7K
STRO icon
911
Sutro Biopharma
STRO
$383M
$119K ﹤0.01%
+2,561
New +$127K
KPTI icon
912
Karyopharm Therapeutics
KPTI
$155M
$119K ﹤0.01%
+4,428
New +$191K
JANX icon
913
Janux Therapeutics
JANX
$917M
$119K ﹤0.01%
+10,010
New +$134K
KURA icon
914
Kura Oncology
KURA
$834M
$118K ﹤0.01%
+11,175
New +$132K
AUTL
915
Autolus Therapeutics
AUTL
$378M
$118K ﹤0.01%
+49,527
New +$118K
NIO icon
916
NIO
NIO
$11.7B
$118K ﹤0.01%
12,136
+509
+4% +$4.31K
AGEN
917
Agenus
AGEN
$261M
$116K ﹤0.01%
+3,626
New +$116K
FHTX icon
918
Foghorn Therapeutics
FHTX
$297M
$116K ﹤0.01%
+16,471
New +$115K
LTHM
919
DELISTED
Livent Corporation
LTHM
$116K ﹤0.01%
4,214
+168
+4% +$4.03K
NRG icon
920
NRG Energy
NRG
$27.2B
$115K ﹤0.01%
+3,087
New +$105K
PRLD icon
921
Prelude Therapeutics
PRLD
$375M
$114K ﹤0.01%
+25,428
New +$152K
REG icon
922
Regency Centers
REG
$15B
$114K ﹤0.01%
1,850
-1,251
-40% -$74.4K
INSP icon
923
Inspire Medical Systems
INSP
$1.49B
$114K ﹤0.01%
351
-7
-2% -$2K
ACLX
924
DELISTED
Arcellx
ACLX
$114K ﹤0.01%
+3,596
New +$137K
TECK icon
925
Teck Resources
TECK
$28.3B
$113K ﹤0.01%
2,692
+448
+20% +$19.3K

Similar funds

Exchange Traded Concepts's Q2 2023 Portfolio in Review

As of Q2 2023, Exchange Traded Concepts held 1,420 positions worth $4.06B, up 11% from $3.65B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Exchange Traded Concepts deployed $205M of net new capital in Q2 2023, opening 288 new positions and adding to 397 existing holdings. Its largest new stake was Vanguard Long-Term Bond ETF: 2,114,708 shares worth $158M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was iShares 0-3 Month Treasury Bond ETF, an estimated $730M trimmed.

  • Exchange Traded Concepts's largest Q2 2023 buy was Vanguard Long-Term Bond ETF: 2,114,708 shares worth $158M.
  • Exchange Traded Concepts added most to Vanguard Long-Term Treasury ETF in Q2 2023, an estimated $69.8M increase.
  • Exchange Traded Concepts's biggest Q2 2023 reduction was iShares 0-3 Month Treasury Bond ETF, cutting an estimated $730M.
  • Exchange Traded Concepts fully exited Goldman Sachs Access Treasury 0-1 Year ETF in Q2 2023, selling an estimated $487M.
  • Exchange Traded Concepts's ten largest holdings make up 22% of its $4.06B portfolio in Q2 2023.
  • Exchange Traded Concepts opened 288 new positions and closed 115 in Q2 2023.
  • Exchange Traded Concepts's portfolio value rose 11% quarter-over-quarter to $4.06B.

Based on Exchange Traded Concepts's 13F filing for Q2 2023, filed 20 Jul 2023.